How Montana negotiated lower healthcare costs

Rising healthcare costs aren’t good for workers or employers, which wind up shouldering higher costs even though employers could negotiate better prices with insurance companies, NPR and ProPublica reported.

Managing benefits for employees is tough business for employers, which is why many just cede their control to health insurers. However, harder negotiating tactics from more knowledgeable administrators can lead to big payoffs.

Employers may not even realize they are wittingly deferring to the healthcare industry to set costs without having much input. The relationship between employers’ health plans and the greater healthcare industry was put to the test when a Montana plan attempted to lower prices for employees—and call the industry’s bluff.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.